Breakout Stocks of Week 16 @ XLON
NASDAQ was down last week (week 15) by -0.452% ending at 16,175.09 points after falling -73.43 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Poolbeg Pharma PLC XLON:POLB. This stock has had a buy signal since Apr 04, 2024 when the price was £10.40 , but have so far fallen -5.77% to £9.80. Some other companies are on our watchlist to, among these are Mobius Investment Trust Plc XLON:MMIT Gemfields Group Limited XLON:GEM Ishares J.p. Morgan $ Em Bond Eur Hedged Ucits Etf (dist) XLON:EMBE and Ishares Core £ Corp Bond Ucits Etf XLON:SLXX which all got a breakout pattern emerging.
| Date | Company | Price | Week 16 |
|---|---|---|---|
| Poolbeg Pharma Plc | £9.80 | £10.60 | 8.16% |
| Mobius Investment Trust Plc | £135.00 | £129.50 | -4.07% |
| Gemfields Group Limited | £12.00 | £11.38 | -5.17% |
| Ishares J.p. Morgan $ Em Bond Eur Hedged Ucits Etf... | 66.14€ | 65.32€ | -1.24% |
| Ishares Core £ Corp Bond Ucits Etf | £122.15 | £121.53 | -0.508% |
The Poolbeg Pharma PLC stock price fell by -0.508% on the last day (Friday, 12th Apr 2024) from £9.85 to £9.80. During the last trading day the stock fluctuated 3.63% from a day low at £9.65 to a day high of £10.00. The price has fallen in 4 of the last 10 days but is still up by 1.55% over the past 2 weeks. Volume has increased on the last day by 921 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately £15.17 million.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Poolbeg Pharma PLC stock to perform well in the short-term.
About Poolbeg Pharma PLC:
Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an inlicensed firstinclass intranasally administered RNAbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
The Mobius Investment Trust Plc stock price gained 0.746% on the last trading day (Friday, 12th Apr 2024), rising from £134.00 to £135.00. During the last trading day the stock fluctuated 2.27% from a day low at £132.00 to a day high of £135.00. The price has fallen in 5 of the last 10 days but is still up by 0.75% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 90 thousand more shares were traded than the day before. In total, 172 thousand shares were bought and sold for approximately £23.16 million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Mobius Investment Trust Plc stock to perform well in the short-term period.
About Mobius Investment Trust Plc:
Mobius Investment Trust PLC is a closed-ended fund launched and managed by Mobius Capital Partners LLP. It invests in the public equity markets of emerging or frontier markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in stocks of small and mid-cap companies. Mobius Investment Trust PLC was formed on August 7, 2018 and is domiciled in the United Kingdom.
The Gemfields Group Limited stock price gained 2.13% on the last trading day (Friday, 12th Apr 2024), rising from £11.75 to £12.00. During the last trading day the stock fluctuated 4.35% from a day low at £11.50 to a day high of £12.00. The price has fallen in 4 of the last 10 days and is down by -4% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 564 thousand more shares were traded than the day before. In total, 625 thousand shares were bought and sold for approximately £7.50 million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Gemfields Group Limited stock to perform well in the short-term period.
Ishares J.p. Morgan $ Em Bond Eur Hedged Ucits Etf (dist)
XLON:EMBEThe Ishares J.p. Morgan $ Em Bond Eur Hedged ETF price gained 0.0605% on the last trading day (Friday, 12th Apr 2024), rising from 66.10€ to 66.14€. During the last trading day the ETF fluctuated 0.484% from a day low at 66.05€ to a day high of 66.37€. The price has been going up and down for this period, and there has been a -1.61% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 33 thousand more shares were traded than the day before. In total, 39 thousand shares were bought and sold for approximately 2.60€ million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
The Ishares Core £ Corp Bond Ucits Etf ETF price gained 0.428% on the last trading day (Friday, 12th Apr 2024), rising from £121.63 to £122.15. During the last trading day the ETF fluctuated 0.542% from a day low at £121.78 to a day high of £122.44. The price has been going up and down for this period, and there has been a -1.16% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 thousand more shares were traded than the day before. In total, 18 thousand shares were bought and sold for approximately £2.14 million.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
